Skip to main content
. 2021 Apr 20;12:662089. doi: 10.3389/fneur.2021.662089

Table 3.

Differences in cerebral physiology to bolus hyperosmolar therapy after intracranial hypertension.

Physiologic variable Difference with treatment responsiveness [median (IQR)] Difference with treatment unresponsiveness [median (IQR)] p-value
ICP, median (mmHg) −1.66 (3.38) +2.14 (2.910) 0.0064
ABP, median (mmHg) −0.67 (4.19) +0.31 (5.26) 0.0126
HR, median (bpm) −1.00 (7.64) +0.32 (6.38) 0.8903
PRx, median −0.04 (0.22) +0.02 (0.24) 0.0063
PAx, median −0.06 (0.25) +0.02 (0.25) 0.0725
wPRx, median −0.03 (0.27) −0.01 (0.25) 0.2610
RAC, median −0.01 (0.17) −0.03 (0.19) 0.3672
RAP, median −0.01 (0.31) +0.03 (0.11) 0.0756
AMP, median −0.10 (0.40) +0.16 (0.46) 0.0795
HRsd, median −0.06 (0.83) −0.03 (0.40) 0.0408
HRrmssd, median −0.38 (5.06) +0.04 (2.56) 0.5242
LHF Ratio, median +0.05 (1.08) +0.00 (0.29) 0.8476

Analysis performed using generalized estimating equations. Bold variables are representative of statistical significance. ICP, intracranial pressure; ABP, arterial blood pressure; HR, heart rate; bpm, beats per minute; mmHg, millimeters of mercury; PRx, pressure reactivity index; PAx, pulse amplitude index; wPRx, wavelet-pressure reactivity; RAC, correlation coefficient between intracranial pressure pulse amplitude and cerebral perfusion pressure; RAP, correlation coefficient between intracranial pressure pulse amplitude and intracranial pressure; AMP, intracranial pressure pulse amplitude; HRsd, standard deviation of heart rate; HRrmssd, root mean square of successive differences of heart rate; LHF, low frequency-high frequency ratio.